| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/29/2003 | EP1278837A2 Internal de novo initiation sites of the hcv ns5b polymerase and use thereof |
| 01/29/2003 | EP1278830A2 Identification and uses of a hyaluronan receptor |
| 01/29/2003 | EP1278829A2 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
| 01/29/2003 | EP1278826A1 Novel proteins |
| 01/29/2003 | EP1278778A2 Modified peptides, comprising an fc domain, as therapeutic agents |
| 01/29/2003 | EP1278777A2 G protein coupled receptor (gpcr) agonists and antagonists and methods of activating and inhibiting gpcr using the same |
| 01/29/2003 | EP1278776A2 Isolated human transporter proteins, nucleic acids and uses thereof |
| 01/29/2003 | EP1278775A2 Isolated human g-protein coupled receptors that are members of the aminergic subfamily, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 01/29/2003 | EP1278774A2 Human g-protein coupled receptors |
| 01/29/2003 | EP1278773A2 Selectable cell surface marker genes |
| 01/29/2003 | EP1278772A2 Glucagon antagonists |
| 01/29/2003 | EP1278771A2 A method for activating only the vascular endothelial growth factor receptor-3 and uses thereof |
| 01/29/2003 | EP1278770A1 Human wingless-like gene |
| 01/29/2003 | EP1278769A2 Tuberculosis antigens and methods of use thereof |
| 01/29/2003 | EP1278768A1 Method for identifying helicobacter antigens |
| 01/29/2003 | EP1278767A1 Albumin fusion proteins |
| 01/29/2003 | EP1278766A2 Polynucleotides for diagnosing mammary gland cancer |
| 01/29/2003 | EP1278765A2 Immunodominant acetylcholine receptor alpha subunit peptides, complexes thereof with mhc class ii components and their use |
| 01/29/2003 | EP1278764A2 Compounds and methods for the treatment and prevention of bacterial infection |
| 01/29/2003 | EP1278550A1 Synergistic improvements to polynucleotide vaccines |
| 01/29/2003 | EP1278544A2 Albumin fusion proteins |
| 01/29/2003 | EP1278542A2 Molecular antigen arrays and vaccines |
| 01/29/2003 | EP1278540A2 Use of il-18 inhibitors for the treatment and/or prevention of atherosclerosis |
| 01/29/2003 | EP1278535A2 Uses of tgap7 for the modulation of leucocyte activation |
| 01/29/2003 | EP1278534A1 Methods and compositions for impairing multiplication of hiv-1 |
| 01/29/2003 | EP1265570A4 Soluble keratin peptide |
| 01/29/2003 | EP1002110B1 Immune responses against hpv antigens elicited by compositions comprising an hpv antigen and a stress protein or an expression vector capable of expression of these proteins |
| 01/29/2003 | EP0961824A4 Method of activating dendritic cells |
| 01/29/2003 | EP0858465B1 Anti-tumoral protein |
| 01/29/2003 | EP0832297B1 Method for identifying compounds modulating bone growth |
| 01/29/2003 | EP0832081B1 Bicyclic-aromatic compounds |
| 01/29/2003 | EP0754192B1 Circularly permuted ligands and circularly permuted chimeric molecules |
| 01/29/2003 | EP0753005B1 Cytotoxic t-cell lymphocyte ("ctl") activity regulation by class i mhc peptides |
| 01/29/2003 | EP0648222B1 Methods of single nucleotide primer extension to detect specific alleles and kits therefor |
| 01/29/2003 | CN1393474A Affinity peptide of tumor necrosis factor receptor and its application |
| 01/29/2003 | CN1393473A Polypeptide-phorbolester/diglyceride protein-9.57 and polynucleotide for coding it |
| 01/29/2003 | CN1393472A Polypeptide-Sec24 protein-31.35 and polynucleotide for coding it |
| 01/29/2003 | CN1393471A Polypeptide-zinc finger protein-78.54 and polynucleotide for coding it |
| 01/29/2003 | CN1393470A Polypeptide-beta transducin-45.65 and polynucleotide for coding it |
| 01/29/2003 | CN1393469A Polypeptide-prop-cell junction associated protein-24.86 and polynucleotide for coding it |
| 01/29/2003 | CN1393468A Polypeptide-fibrinogen-42.68 and polynucleotide for coding it |
| 01/29/2003 | CN1393467A Polypeptide-human thymocyte signal transducer-14.52 and polynucleotide for coding it |
| 01/29/2003 | CN1393466A Polypeptide-ribonucleic acid bindin-31.13 and polynucleotide for coding it |
| 01/29/2003 | CN1393465A Polypeptide-human protein-12.43 containing ribosomal protein S24e characteristic sequence fragment and polynucleotide for coding it |
| 01/29/2003 | CN1393464A Polypeptide-growth factor receptor-15.95 and polynucleotide for coding it |
| 01/29/2003 | CN1393463A Polypeptide-accessory factor-15.84 and polynucleotide for coding it |
| 01/29/2003 | CN1393462A Polypeptide-membrane transporter-14.85 and polynucleotide for coding it |
| 01/29/2003 | CN1393461A Polypeptide-iodothyrine transporter-22.88 and polynucleotide for coding it |
| 01/29/2003 | CN1393460A Polypeptide-reticulocyte finger protein-31.57 and polynucleotide for coding it |
| 01/29/2003 | CN1393459A Polypeptide-bone development associated protein-43.23 and polynucleotide for coding it |
| 01/29/2003 | CN1393458A Polypeptide-C2 function region contained protein-56.65 and polynucleotide for coding it |
| 01/29/2003 | CN1393457A Polypeptide-Na/glucose cotransporter family-72.05 and polynucleotide for coding it |
| 01/29/2003 | CN1393456A Polypeptide-zinc finger protein-61.05 and polynucleotide for coding it |
| 01/29/2003 | CN1393455A Polypeptide-zinc finger protein-57.86 and polynucleotide for coding it |
| 01/29/2003 | CN1393454A Polypeptide-human macroprotein-31.68 and polynucleotide for coding it |
| 01/29/2003 | CN1393453A Activator protein for fibrin dissolving system |
| 01/29/2003 | CN1393452A Memory clearing protein and its application |
| 01/29/2003 | CN1100143C Control of leaf scald disease |
| 01/28/2003 | USRE37971 Selective acylation of epsilon-amino groups |
| 01/28/2003 | US6512163 RANK1, an ankyrin-repeat containing peptide from rice associated with disease resistance |
| 01/28/2003 | US6512162 Nucleotide sequences for use in genetic engineering of plant organelle |
| 01/28/2003 | US6512161 Genomic DNA sequences that encode apolipoprotein (A) and apolipoprotein B polypeptides |
| 01/28/2003 | US6512103 Mammalian chemokine reagents |
| 01/28/2003 | US6512098 Chemically modified proteins with a carbohydrate moiety |
| 01/28/2003 | US6512096 Prostate cell surface antigen-specific antibodies |
| 01/28/2003 | US6512095 Nucleotide sequeces coding protein for use in the detetion, diagnosis and treatment cell proliferative, autoimmune diseases and infection |
| 01/28/2003 | US6512091 BRCA1 mutations, PCR primers and hybridization probes used in nucleic acid-based methods for diagnosis; presence or absence of the translation product of BRCA1 alleles |
| 01/28/2003 | US6512003 Synthetic spiroketal pyranes as potent anti-cancer agents and use |
| 01/28/2003 | US6511963 Treating excitotoxicity resulting from over- stimulation of the NMDA receptor which comprises administering agent selected from the group consisting of Conantokin-G, a Conantokin-G derivative and salts thereof |
| 01/28/2003 | US6511961 Treating allergic inflammatory disease or hepatitis comprising administering to a subject an effective amount of a cyclic peptide having VLA-4 (very late antigen-4) adhesion activity |
| 01/28/2003 | US6511959 Cytotoxic treatment of tumors selected from the group consisting of carcinomas, melanomas and hematological malignancies, which comprises administering for CANP, thus inhibiting growth of the tumors |
| 01/28/2003 | US6511957 Corneocyte envelope protein or polypeptide in an amount sufficient to provide a protective layer on said skin, hair or nails |
| 01/28/2003 | US6511847 Recombinant adenovirus using liposome-mediated cotransfection and the direct observation of a cytopathic effect in the transfected cells; tumor suppressor gene |
| 01/28/2003 | US6511845 Methods for producing an immune response against HIV-1 |
| 01/28/2003 | US6511830 Envelope protein gp 160 |
| 01/28/2003 | US6511829 Combine the inherent strong visible fluorescent properties of GFPs with the anionic phospholipid binding specificity of annexins; selectively labeling apoptotic cells |
| 01/28/2003 | US6511828 Human and drosophila inhibitors of apoptosis proteins (IAPs) |
| 01/28/2003 | US6511827 Nucleotide encoding human galanin receptor 3 (GALR3) |
| 01/28/2003 | US6511826 For use in diagnosis therapy |
| 01/28/2003 | US6511825 Cell signaling polypeptides and nucleic acids |
| 01/28/2003 | US6511824 Nucleic acids and polypeptides of invertebrate TWIK channels and methods of use |
| 01/28/2003 | US6511823 Novel DNA and amino acid sequences; expression vectors and host cells useful in a method for production of the HBNF protein |
| 01/28/2003 | US6511816 DNA gyrase-inhibiting proteins |
| 01/28/2003 | US6511811 Protein kinase C antagonist related to insulin receptor |
| 01/28/2003 | US6511808 Generating transcriptional control proteins; obtain nucleotide sequences, screen for reguatory sequences, generate transcription control protein, |
| 01/28/2003 | US6511807 Carbohydrate ligand that specifically binds to a leczyme; nucleic acid sequence encoding a nonclassical MHC class I heavy chain; ability to associate with a beta 2 microglobulin; major histocompatibility complex transplantation molecules |
| 01/28/2003 | US6511805 Methods for detecting papillomavirus DNA in blood plasma and serum |
| 01/28/2003 | US6511801 HIV-1 group O strain gp160 env precursor protein comprising the amino acid sequence of SEQ ID NO:100 |
| 01/28/2003 | US6511799 Increased expression of CDX2 gene product indicates candidate drug for cancers with mutant adenomatous polyposis coli alleles; catenin/TCF regulated transcription (CRT) is absent in RKO colorectal cancer cell line; CDX2 mRNA and CDX2 protein |
| 01/28/2003 | US6511665 Antibodies to interleukin-1 receptors |
| 01/28/2003 | US6511664 Antiinflammatory |
| 01/28/2003 | CA2318432C The use of isolated domains of type iv collagen to modify cell and tissue interactions |
| 01/28/2003 | CA2191950C Technetium-99m labeled peptides for imaging |
| 01/28/2003 | CA2127553C Peptides with organo-protective activity, process for their preparation and their use in the therapy |
| 01/28/2003 | CA2072008C Immunologically active proteins from borrelia burgdorferi, related test kits which contain these proteins and are suitable for detecting antibodies in test fluids, and the use of these proteins as vaccines against infections caused by borrelia strains |
| 01/27/2003 | CA2391642A1 Identification and use of molecules implicated in pain |
| 01/27/2003 | CA2391219A1 Identification and use of molecules implicated in pain |
| 01/27/2003 | CA2391216A1 Identification and use of molecules implicated in pain |
| 01/27/2003 | CA2391112A1 Identification and use of molecules implicated in pain |
| 01/23/2003 | WO2003007187A1 Method of presuming ligand and method of using the same |